Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10660971 Compounds for targeted immunotherapy

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 20, 2017
0
Date of Patent
May 26, 2020
0
Patent Application Number
15849470
0
Patent Citations
‌
US Patent 10328158 Compounds and compositions for immunotherapy
0
Patent Citations Received
‌
US Patent 11517567 Pharmaceutical compositions
‌
US Patent 11400164 Immunoconjugates targeting HER2
‌
US Patent 11834448 2-amino-quinoline derivatives
0
‌
US Patent 11998620 PSMA targeted compounds and uses thereof
0
‌
US Patent 11547761 Antibody adjuvant conjugates
‌
US Patent 11633495 Compounds and compositions for immunotherapy
0
‌
US Patent 11633494 Compounds and compositions for immunotherapy
0
‌
US Patent 11708393 Targeted non-invasive imaging probes of EGFR expressing cells
0
‌
US Patent 11786604 Compounds and compositions for treating HER2 positive tumors
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10660971
0
Patent Primary Examiner
‌
Shulamith H. Shafer
0

Find more entities like US Patent 10660971 Compounds for targeted immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo